Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lampert

Showing results (251-260 of 265) with videos related to

Pageof 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocationJ Corral, A Forster, S Thompson, et al.
Leukemia|January 1, 1995
Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study groupH Behrendt, C Charrin, B Gibbons, et al.
Medical and Pediatric Oncology|August 1, 1997
CNS late effects after ALL therapy in childhood. Part II: Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL--an evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. German Late Effects Working GroupM A Ueberall, D Wenzel, H Hertzberg, et al.
Leukemia|May 21, 1998
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster GroupM Dördelmann, M Schrappe, A Reiter, et al.
Oncogene|September 1, 1999
A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cellsE Gillert, T Leis, R Repp, et al.
Blood|October 9, 1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcomeM Schrappe, M Aricò, J Harbott, et al.
Klinische Padiatrie|July 1, 1982
[Neuroblastoma study NBL 79 of the German Society for Pediatric Oncology. Report after 2 years]F Berthold, J Treuner, W E Brandeis, et al.
Blood|July 15, 1997
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study GroupA Borkhardt, G Cazzaniga, S Viehmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2000
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5qA Borkhardt, S Bojesen, O A Haas, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
Pageof 27

Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocationJ Corral, A Forster, S Thompson, et al.
Leukemia|January 1, 1995
Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study groupH Behrendt, C Charrin, B Gibbons, et al.
Medical and Pediatric Oncology|August 1, 1997
CNS late effects after ALL therapy in childhood. Part II: Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL--an evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. German Late Effects Working GroupM A Ueberall, D Wenzel, H Hertzberg, et al.
Leukemia|May 21, 1998
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster GroupM Dördelmann, M Schrappe, A Reiter, et al.
Oncogene|September 1, 1999
A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cellsE Gillert, T Leis, R Repp, et al.
Blood|October 9, 1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcomeM Schrappe, M Aricò, J Harbott, et al.
Klinische Padiatrie|July 1, 1982
[Neuroblastoma study NBL 79 of the German Society for Pediatric Oncology. Report after 2 years]F Berthold, J Treuner, W E Brandeis, et al.
Blood|July 15, 1997
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study GroupA Borkhardt, G Cazzaniga, S Viehmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2000
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5qA Borkhardt, S Bojesen, O A Haas, et al.
Medical and Pediatric Oncology|July 24, 2001
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?J Vandesompele, F Speleman, N Van Roy, et al.
Pageof 27